The toxin–antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening
Open Access
- 23 September 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (11) , 2978-2988
Abstract
Background: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) has significantly challenged the treatment of S. aureus infection. Toxin–antitoxin (TA) systems have been reported to mediate bacterial stress adaptation and virulence, but their role in vancomycin resistance remains elusive. This study investigated the vancomycin resistance mechanism regulated by the TA system SavRS in VISA. Methods: savRS mutants in Mu50 and XN108 were generated via homologous recombination. To investigate the regulatory mechanism of vancomycin resistance mediated by savRS in VISA, phenotypic analyses including MICs, growth kinetics and cell wall thickness measurements were performed. Expression of cell wall synthesis-related genes was analysed using quantitative RT–PCR (RT–qPCR) and promoter-lacZ reporter assay. Electrophoretic mobility shift assay (EMSA) was performed to assess the binding of SavRS to the promoters of the cell wall synthesis-related genes. Pull-down assay identified an upstream regulatory element of savRS associated with vancomycin resistance. Quantitative assessment of bacterial burden in murine organ systems following vancomycin administration revealed the critical regulatory role of savRS in mediating vancomycin resistance in vivo. Results: Compared with the WT, the savRS mutant exhibited enhanced vancomycin sensitivity, accelerated growth and reduced cell wall thickness. Correspondingly, RT–qPCR revealed marked down-regulation of the cell wall synthesis-related genes (glyS, dltA, scdA, pbp2, ddl). EMSA and promoter-lacZ reporter assay confirmed direct binding of SavRS to a conserved promoter motif, MGHYYTCCTCA. Pull-down assay identified UspA as an upstream regulator of SavRS, demonstrating that UspA directly controls savRS transcription and modulates VISA resistance. Mouse infection experiments showed that savRS promotes VISA to vancomycin resistance in vivo. Conclusions: SavRS critically regulates vancomycin resistance in VISA.Keywords
Funding Information
- National Natural Science Foundation of China (32370184)
- Natural Science Foundation of Anhui Province, China (2408085MC061)
- Fundamental Research Funds for the Central Universities (WK9100000080)
- USTC Research Funds of the Double First-Class Initiative (YD9100002063)
This publication has 46 references indexed in Scilit:
- Composite Mapping for Peptide‐Based Data Storage with Higher Coding Density and Fewer Synthesis CyclesAdvanced Science, 2025
- Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a reviewInternational Journal of Antimicrobial Agents, 2023
- Toxin–antitoxin systems: Classification, biological roles, and applicationsMicrobiological Research, 2022
- Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitorsClinical Microbiology and Infection, 2017
- Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012–2013Journal of Microbiology, Immunology and Infection, 2016
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Role of the universal stress protein UspA of Salmonella in growth arrest, stress and virulenceMicrobial Pathogenesis, 2007
- The bacterial universal stress protein: function and regulationCurrent Opinion in Microbiology, 2003
- Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001
- Mechanism of post‐segregational killing: Sok antisense RNA interacts with Hok mRNA via its 5′‐end single‐stranded leader and competes with the 3′‐end of Hok mRNA for binding to the mok translational initiation region.The EMBO Journal, 1994